Early Labs
Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.
About
Early Labs is developing a novel, proprietary multi-cancer screening platform that utilizes Volatile Organic Compound (VOC) biomarkers for early cancer detection. Their Biosensor Platform (BSP) Urine Test aims to make cancer screening accurate, accessible, affordable, and acceptable for patients, payers, policymakers, and providers. This non-invasive, self-administered test seeks to increase survival rates and improve quality of life by identifying cancer at its earliest stages. Teams look it up for Healthcare, Oncology, Detection.
Frequently asked
What does Early Labs do?
Early Labs is a Healthcare company that offers Platform. Teams look it up for Oncology, Detection, Urine. It is based in Tel Aviv, Israel and was founded in 2017. Public records show about 7 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Early Labs headquartered?
Early Labs is headquartered in Tel Aviv, Israel.
When was Early Labs founded?
Early Labs was founded in 2017.
What industry does Early Labs operate in?
Early Labs operates in Healthcare, Oncology, Detection, Urine, Diagnostics.
How many employees does Early Labs have?
Early Labs has approximately 7 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.